三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
AK104同靶点研发竞争格局(截至2025年5月31日)
AK104同靶点研发竞争格局(截至2025年5月31日)
竞争格局
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:205KB
图片尺寸:2280*856
同报告图片
/
4
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
所属报告:
康方生物-港股公司研究报告-全球双抗龙头依沃西引领二代IO新时代-250707(29页).pdf
打包全文图表
相关数据
ZG005和AK104在宫颈癌的数据对比(截至20250720)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
AK104宫颈癌1L治疗注册临床安全性数据
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yM6KGo5qC85LiL5pa55bGV56S65LqG6LWE5paZ5p2l5rqQ44CCCgp8IOS4jeiJr+S6i+S7tuexu+WeiyB8IOivlemqjOe7hOWPkeeUn+eOhyB8IOWvueeFp+e7hOWPkeeUn+eOhyB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDiiaUz57qn5rK755aX55u45YWz5LiN6Imv5LqL5Lu2IChURUFFKSB8IDg1LjQwJSAgICAgICB8IDgwLjQwJSAgICAgICB8Cnwg5Lil6YeN5LiN6Imv5LqL5Lu2IChTQUUpICAgICAgICAgfCA1NS44MCUgICAgICAgfCAzMy44MCUgICAgICAgfAp8IOayu+eWl+S4reaWreeOhyAoRGlzY29udGludWF0aW9uKSB8IDI3LjkwJSAgICAgICB8IDEwLjUwJSAgICAgICB8Cnwg4omlM+e6p+WFjeeWq+ebuOWFs+S4jeiJr+S6i+S7tiAoaXJBRSkgfCA5LjcwJSAgICAgICAgfCAwLjkwJSAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaTGFuY2V077yM5Lic5ZC06K+B5Yi456CU56m25omA
收藏
行业数据
2025-07-08
原图定位
查看详情
K药、AK112、AK104适应症布局梳理(绿色为获批,蓝色为III期,黄色为II期)
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
收藏
行业数据
2025-07-08
原图定位
查看详情
AK104销售预测(单位均为亿人民币)
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
收藏
行业数据
2025-07-08
原图定位
查看详情
AK104与Volrustomig的安全性比较(NSCLC)
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
收藏
行业数据
2025-07-08
原图定位
查看详情
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
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
收藏
其它
2024-07-10
原图定位
查看详情
AK104治疗一线宫颈癌对比联合疗法适用患者增加PD-L1CPS<1部分,III期研究已达PFS终点
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
收藏
其它
2024-06-25
原图定位
查看详情
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比
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
收藏
其它
2024-06-25
原图定位
查看详情
AK104作为免疫疗法针对PD-L1低表达一线胃癌亦有优越的长期获益
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
收藏
其它
2024-06-25
原图定位
查看详情
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效
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
收藏
其它
2024-06-25
原图定位
查看详情
AK104治疗一线胃癌临床数据对比
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
收藏
行业数据
2023-05-08
原图定位
查看详情
AK104总盈利预测
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
收藏
行业数据
2023-05-08
原图定位
查看详情
AK104与其他宫颈癌药物对比
fCBEcnVnIHwgT1JSIHwgQ1IgfCBtT1MgKG1vbnRoKSB8CnwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwKfCBDYWRvbmlsaW1hYiAoTj0xMDApIHwgMzMuMCUgfCAxMi4wJSB8IDE3LjUgfAp8IEJhbHN0aWxpbWFiICsgWmFsaWZyZWxpbWFiIChOPTEyNSkgfCAyNS42JSB8IDguMCUgfCAxMi4wIHwKfCBCYWxzdGlsaW1hYiAoTj0xNDApIHwgMTQuMCUgfCAyLjAlIHwgMTIuOCB8CnwgQ2VtaXBsaW1hYiAoTj0zMDQpIHwgMTYuMCUgfCAzLjMlIHwgMTIuMCB8CnwgQ2Fkb25pbGltYWIgKE49NjQpIHwgNDMuOCUgfCAxNy4yJSB8IDE3LjUgfAp8IFppbWJlcmVsaW1hYiAoTj0xMDUpIHwgMzIuOCUgfCAyMS4wJSB8IDEyLjAgfAp8IEJhbHN0aWxpbWFiICsgWmFsaWZyZWxpbWFiIChOPTY3KSB8IDIwLjAlIHwgMi45JSB8IDEyLjggfAp8IEJhbHN0aWxpbWFiIChOPTE0MCkgfCAxNC42JSB8IDIuMCUgfCAxMi4wIHwKfCBQZW1icm9saXp1bWFiIChOPTgyKSB8IDMuNyUgfCAzLjclIHwgMTIuMCB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlrpjnvZHvvIzlvrfpgqbnoJTnqbbmiYA=
收藏
行业数据
2023-05-08
原图定位
查看详情
AK104-宫颈癌适应症盈利预测
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
收藏
行业数据
2023-05-08
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
康方生物的 AK104 是目前唯一一款以上市的 PD-1/CTLA-4 双抗。目前全球有 7 款PD-1/CTLA-4 双抗处于临床阶段,布局企业包括康方生物、康宁杰瑞、AstraZeneca、百利天恒等企业。其中 MacroGenics、Xencor 仅在海外开展临床试验,布局的适应症也较少。科伦博泰的双抗产品目前临床进展较慢,适应症尚未区分癌种的实体瘤,而百利天恒则仍然处于 II 期临床。康宁杰瑞则由于 III 期临床揭盲失败所以开发陷入停滞。AstraZeneca 的 Volrustomig 是仅次于 AK104 的 PD-1/CTLA-4 双抗,其在 2025 年 1 月对其代号为 eVOLVE-Cervical 的全球 III 期临床试验进行了登记,针对适应症为高风险局部晚期宫颈癌。相比之下,康方生物的 AK104 已经进入适应症的广泛拓展期,目前在国内已有 3 项适应症获批,同时正在进行中的临床试验还布局鼻咽癌、非小细胞肺癌、淋巴癌及肝癌等多个适应症,研发进程排在前列并表现出更为优秀的疗效。
竞争格局
原图定位
当前图表所属:
康方生物-港股公司研究报告-全球双抗龙头依沃西引领二代IO新时代-250707(29页).pdf
K药、AK112、AK104适应症布局梳理(绿色为获批,蓝色为III期,黄色为II期)
AK104销售预测(单位均为亿人民币)
AK104联用仑伐替尼+TACE治疗不可切除肝细胞癌的II期临床数据
AK104宫颈癌1L治疗注册临床安全性数据
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》